Pediatrix Medical Group, Inc. - MD STOCK NEWS

Mednax, Inc. (NYSE: MD) will present at J.P. Morgan’s 2022 Global High Yield and Leveraged Finance Conference on February 28, 2022, at 10:00 a.m. ET in Miami. The event will be accessible through live audio webcasts. Mednax is known for providing physician services under the Pediatrix brand, specializing in pediatric and maternal-fetal care with over 4,700 affiliated clinicians across 38 states and Puerto Rico. Founded in 1979, the company emphasizes high-quality, evidence-based care, supported by a strong commitment to research and education.

Mednax, Inc. (NYSE: MD) is set to present at SVB Leerink’s 11th Annual Global Healthcare Conference on February 18, 2022, at 8:40 a.m. ET. This virtual event will feature a live audio webcast for investors. Mednax is a national medical group focused on providing high-quality physician services through its Pediatrix brand, offering care in specialties such as obstetrics and neonatology. The company has over 4,700 affiliated clinicians across 38 states and Puerto Rico, emphasizing coordinated, compassionate medical care.

Mednax, Inc. (NYSE: MD) reported Q4 2021 earnings of $0.47 per share, with an Adjusted EPS of $0.52. The company achieved net revenue of $499 million, up from $416.6 million YoY, while income from continuing operations rose to $68 million. Adjusted EBITDA for the quarter was $81 million, benefiting from $18.4 million in provider relief funds. For 2021, total revenue reached $1.91 billion, with net income of $108 million, or $1.26 per share. Mednax anticipates at least $270 million in Adjusted EBITDA for 2022, excluding further relief fund contributions.

Mednax, Inc. (NYSE: MD) announced the successful issuance of $400 million in unsecured 5.375% Senior Notes due 2030 and a new $450 million Revolving Credit Facility, replacing a $600 million facility. The proceeds were utilized to redeem $1 billion in 6.25% Senior Notes due 2027. Post-transaction, Mednax’s outstanding debt stands at approximately $750 million. The Notes were sold to qualified institutional buyers without registration under the Securities Act.

Mednax, Inc. (NYSE: MD) will hold an investor conference call and webcast on February 17, 2022, at 9:00 a.m. ET, to discuss operational results for the year ended December 31, 2021. A detailed press release will precede the call on the same date. Mednax, a national medical group, specializes in physician services primarily in pediatrics, obstetrics, and neonatology, operating across 38 states and Puerto Rico with over 4,700 clinicians. For more information, visit mednax.com/investors.

Mednax, Inc. (NYSE: MD) has acquired Night Lite Pediatrics, LLC, a pediatric urgent care practice with 13 clinics in Florida. Founded in 2005, Night Lite employs 30 physicians and offers urgent care, telemedicine, and COVID-19 services. This cash transaction is expected to be immediately accretive to earnings, enhancing Mednax's strategy to develop innovative pediatric services powered by Brave Care technology. The clinics will be rebranded to Pediatrix, further expanding Mednax's presence in pediatric care in Florida.

Mednax, Inc. (NYSE: MD) has priced a private offering of $400 million of 5.375% Senior Notes due in 2030. The offering is set to close on February 11, 2022, subject to customary conditions. Net proceeds will be used to redeem existing 6.25% Senior Notes due in 2027. The Notes will be sold exclusively to qualified institutional buyers and non-U.S. persons, in accordance with Rule 144A and Regulation S of the Securities Act.

Mednax, Inc. (NYSE: MD) is proposing a private offering of $400 million in Senior Notes due 2030. The offering is exempt from registration under the Securities Act of 1933 and will be directed to qualified institutional buyers. The proceeds will be used to redeem outstanding 6.25% Senior Notes due 2027. The company aims to improve its financial position and reduce interest expenses. This move reflects Mednax's ongoing strategy to optimize its capital structure amidst changing market conditions.

Mednax, Inc. (NYSE: MD) will present at Bank of America’s 2021 Leveraged Finance Conference on November 30, 2021, at 2:15 p.m. EST. The presentation will be available via live audio webcasts. Mednax, founded in 1979, is a national medical group that provides physician services through its Pediatrix and Obstetrix medical groups. The company operates with over 2,300 physicians in 39 states and Puerto Rico, focusing on evidence-based care and enhancing patient outcomes.